Skip to content

Using talking therapies in general practice to treat pain-related insomnia

Primary care treatment of pain-related insomnia: A feasibility study of a hybrid cognitive-behavioural approach

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN17294365
Enrollment
48
Registered
2019-01-08
Start date
2016-04-26
Completion date
Unknown
Last updated
2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Specialty: Primary Care, Primary sub-specialty: Primary Care

Interventions

Hybrid CBT comprised select components of CBT-I and interventions designed to target cognitive-behavioural processes maintaining chronic pain, based on Tang et al. (2014). Each patient was offered a t

Sponsors

University of Warwick
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 years or above 2. A history of chronic pain and insomnia (as indicated by medical records) 3. Pain of at least moderate severity (>4/10 on the present pain intensity numerical rating scale of the BPI) for at least 6 months 4. Clinical insomnia (>15 on the ISI, >3 nights a week, >1 moth in duration)

Exclusion criteria

Exclusion criteria: 1. Diagnosed/suspected medical/psychiatric/sleep disorders (e.g. narcolepsy) for which CBT-I is contraindicated as firstline treatment 2. Recently enrolled in or are completing a pain management programme or other psychological treatments for pain or sleep

Design outcomes

Secondary

MeasureTime frame
1. Pain intensity will be measured using the BPI - pain intensity scores at 12-weeks and 24-weeks post-randomisation. 2. Fatigue will be measured using the Multidimensional Fatigue Inventory at 12-weeks and 24-weeks post-randomisation. 3. Anxiety and depression will be measured using the Hospital Anxiety and Depression Scale at 12-weeks and 24-weeks post-randomisation. 4. Quality of life will be measured using EuroQol - EQ- 5D at 12-weeks and 24-weeks post-randomisation.

Primary

MeasureTime frame
1. Insomnia Severity will be using the Insomnia Severity Index (ISI) - total score at 12-weeks and 24-weeks post-randomisation. 2. Pain Interference will be measured using the Brief Pain Inventory (BPI) - Interference Score minus the sleep item at 12-weeks and 24-weeks post-randomisation.

Countries

United Kingdom

Contacts

Public ContactNicole Tang
n.tang@warwick.ac.uk024 76150556

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 19, 2026